Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis



      To determine whether the biochemical presentation and urinary physicochemical environment of patients with hyperuricosuria presenting with calcium stones (hyperuricosuric calcium urolithiasis [HUCU]) differs from those of patients with gouty diathesis (GD) or idiopathic uric acid urolithiasis.


      A total of 122 patients with HUCU and 68 patients with GD were identified from our “stone registry” of patients who underwent a full ambulatory evaluation. All patients with HUCU had urinary uric acid greater than 800 mg/day in men and greater than 750 mg/day in women and presented with calcium stones. Those with GD had pure uric acid stones or mixed uric acid-calcium stones and did not have secondary causes of uric acid urolithiasis. Data derived from the fasting serum and 24-hour urine samples collected on a random diet and on a diet restricted in calcium, sodium, and oxalate were compared between the two groups.


      Compared with patients with HUCU, those with GD had significantly higher serum uric acid and lower urinary uric acid and pH levels (mean value 5.38 and 5.35 on random and restricted diets versus 6.09 and 6.14, respectively). The fractional excretion of urate and the discriminant score of the relationship between urinary pH and the fractional excretion of urate were significantly lower in those with GD than in those with HUCU. Patients with HUCU displayed a greater urinary saturation of sodium urate and calcium oxalate compared with those with GD, and those with GD had a higher urinary content of undissociated uric acid and lower urinary saturation of brushite (calcium phosphate).


      Patients with HUCU presented with normal urinary pH and hyperuricosuria, accompanied sometimes by hypercalciuria, which produced increased urinary saturation of sodium urate and calcium oxalate. In contrast, those with GD had a low fractional excretion of urate (that contributed to hyperuricemia) and low urinary pH (that led to increased amount of undissociated uric acid). The varying biochemical and physicochemical presentations of the two conditions can be ascribed to overindulgence with purine-rich foods in those with HUCU and underlying primary gout in those with GD.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Smith M.J.V.
        • Hunt L.D.
        • King Jr, J.S.
        • et al.
        Uricemia and urolithiasis.
        J Urol. 1969; 101: 637-642
        • Smith M.J.V.
        • Boyce W.H.
        Allopurinol and urolithiasis.
        J Urol. 1969; 102: 750-753
        • Coe F.L.
        • Raisin L.
        Allopurinol treatment of uric acid disorders in calcium-stone formers.
        Lancet. 1973; 1: 129-131
        • Coe F.L.
        Hyperuricosuric calcium oxalate nephrolithiasis.
        Kidney Int. 1978; 13: 418-426
        • Ettinger B.
        • Tang A.
        • Citron J.T.
        • et al.
        Randomized trial of allopurinol in the prevention of calcium oxalate calculi.
        N Engl J Med. 1986; 315: 1386-1389
        • Pak C.Y.C.
        • Britton F.
        • Peterson R.
        • et al.
        Ambulatory evaluation of nephrolithiasis.
        Am J Med. 1980; 69: 19-30
        • Coe F.L.
        • Lawton R.L.
        • Goldstein R.B.
        • et al.
        Sodium urate accelerates precipitation of calcium oxalate in vitro.
        Proc Soc Exp Biol Med. 1975; 149: 926-929
        • Pak C.Y.C.
        • Arnold L.H.
        Heterogeneous nucleation of calcium oxalate by seeds of monosodium urate.
        Proc Soc Exp Biol Med. 1975; 149: 930-932
        • Zerwekh J.E.
        • Holt K.
        • Pak C.Y.C.
        Natural urinary macromolecular inhibitors.
        Kidney Int. 1983; 23: 838-841
        • Glover P.K.
        • Ryall R.L.
        • Marshall V.R.
        Dissolved urate promotes calcium oxalate crystallization.
        Clin Sci. 1993; 85: 303-307
        • Pak C.Y.C.
        • Barilla D.E.
        • Holt K.
        Effect of oral purine load and allopurinol on the crystallization of calcium salts in urine of patients with hyperuricosuric calcium urolithiasis.
        Am J Med. 1978; 65: 593-599
        • Pak C.Y.C.
        • Sakhaee K.
        • Fuller C.
        Successful management of uric acid nephrolithiasis with potassium citrate.
        Kidney Int. 1986; 30: 422-428
        • Levy F.L.
        • Adams-Huet B.
        • Pak C.Y.C.
        Ambulatory evaluation of nephrolithiasis.
        Am J Med. 1995; 98: 50-59
        • Khatchadourian J.
        • Preminger G.M.
        • Whitson P.A.
        • et al.
        Clinical and biochemical presentation of gouty diathesis.
        J Urol. 1995; 154: 1665-1669
        • Pak C.Y.C.
        • Sakhaee K.
        • Peterson R.
        • et al.
        Biochemical profile of idiopathic uric acid nephrolithiasis.
        Kidney Int. 2001; 60: 757-761
      1. Resnick MI, Pak CYC: Urolithiasis: A Medical and Surgical Reference. Philadelphia, WB Saunders, 1990, p 168

        • Gutman A.
        • Yu T.F.
        Uric acid nephrolithiasis.
        Am J Med. 1968; 45: 756-779
        • Pak C.Y.C.
        • Skurla C.
        • Harvey J.
        Graphic display of urinary risk factors for renal stone formation.
        J Urol. 1985; 134: 867-870
        • Werness P.G.
        • Brown C.M.
        • Smith L.H.
        Equil 2.
        J Urol. 1985; 134: 1242-1244
      2. Reddy ST, Wang C-Y, and Pak CYC: Effect of low carbohydrate, high protein diets on acid-base balance, stone-forming propensity and calcium metabolism. Am J Kidney Dis 40: 265–274, 2002

        • Wyngaarden J.B.
        • Kelley W.N.
        in: Stanbury J.B. Wyngaarden J.B. Fredrickson D.S. The Metabolic Basis for Inherited Diseases. McGraw-Hill, New York1972: 889-967
      3. Sakhaee K, Adams-Huet B, Moe O, et al: Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int 62: 971–979, 2002

      4. Pak CYC, Waters O, Arnold L, et al: Mechanism for calcium urolithiasis among patients with hyperuricosuria: supersaturation of urine with respect to monosodium urate. J Clin Invest 59: 426–431, 1977

      5. Pak CYC, Pearle MS, and Poindexter JR: Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med (in press)